[by date] [by subject] [by continent]

Cardiovascular Genomics

Buena Vista Palace , Orlando, Florida
January 11-12,1999

Invited Speakers:
Dr. Klaus Lindpaintner, F. Hoffmann-La Roche Ltd. (Switzerland)
Dr. Mark H. Skolnick, Myriad Genetics, Inc.

Dr. Dennis Grant Ballinger, Hyseq, Inc.
Dr. Craig T. Basson, Cornell University Medical College
Dr. D. Woodrow Benson, Medical University of South Carolina
Dr. Suzanne Cheng, Roche Molecular Systems, Inc.
Dr. Giora Z. Feuerstein, SmithKline Beecham Pharmaceuticals R&D
Dr. Alistair S. Hall, The Institute for Cardiovascular Research (United Kingdom)
Dr. Kirk Hammond, University of California, San Diego and Collateral Therapeutics, Inc.
Dr. Fred D. Ledley, Variagenics, Inc.
Dr. Steven Liggett, University of Cincinnati
Dr. Klaus Lindpaintner, F. Hoffmann-La Roche Ltd. (Switzerland)
Dr. John-Louis McGregor, Genset SA (France)
Dr. Howard A. Rockman, University of North Carolina at Chapel Hill
Dr. Daniel Ryan, University of Rochester
Dr. Andrew J. Schwab, Digital Gene Technologies, Inc.
Dr. Mark H. Skolnick, Myriad Genetics, Inc.
Dr. Lawrence W. Stanton, Scios, Inc.
Dr. Qing Wang, Baylor College of Medicine and Texas Children’s Hospital

Polygenic Links to Common Cardiovascular Disorders
Cloning Genes That Predispose to Cardiovascular Disease Risk
Differential Gene Expression Strategies in Cardiovascular Research
Role of b-Adrenergic Receptor Desensitization
The Acute Coronary Event DNA Library (ADLIB) Project
Cardiac Adenylylcyclase Content

Monogenic Links to Cardiovascular Disorders
Polymorphisms in b-Adrenergic Receptor for CHF and in a-Adrenergic Receptor for Hypertension
Genetic Analysis of Human Cardiac Growth and Development
Molecular Genetic Characterization of Idiopathic Ventricular Fibrillation
Mutations in the Transcription Factor NKX2-5
Genotyping Thrombosis-Associated Mutations

Genetic Variation and Pharmacogenomics
Applications of Pharmacogenomics in the Clinical Development of Cardiovascular Therapies
Multilocus Genotyping for Cardiovascular Disease Risk
Polymorphism Analysis for Cardiovascular Disease Applications
Mapping and Sequencing Cardiovascular-Linked Genes

Genetic Analysis for Discovery
Genetics and Drug Discovery: Fact or Fancy, Promise or Peril?
Application of the Robotic TOGA™ Technology to Discover mRNAs Associated with Models of Cardiovascular Disease
Cardiac Gene Expression Profiling in Rat Models

Registration :

Deadline for Abstracts: December 11, 1998

Email for Requests and Registration: cghatak@healthtech.com

Posted by: Carol A. Ghatak Host: date: September 03, 1998 18:09:15
Generated by meetings and positions 1.0 by Kai Garlipp